These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25422468)

  • 1. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
    Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy.
    Kim D; Lim S; Park M; Choi J; Kim J; Han H; Yoon K; Kim K; Lim J; Park S
    Cell Signal; 2014 Sep; 26(9):1774-82. PubMed ID: 24726896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
    Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
    Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.
    Jourdan T; Szanda G; Cinar R; Godlewski G; Holovac DJ; Park JK; Nicoloro S; Shen Y; Liu J; Rosenberg AZ; Liu Z; Czech MP; Kunos G
    Diabetes; 2017 Apr; 66(4):994-1007. PubMed ID: 28082458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling.
    Tung CW; Ho C; Hsu YC; Huang SC; Shih YH; Lin CL
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
    J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
    Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
    Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system within the diabetic podocyte.
    Márquez E; Riera M; Pascual J; Soler MJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.
    Lin CL; Hsu YC; Lee PH; Lei CC; Wang JY; Huang YT; Wang SY; Wang FS
    J Mol Med (Berl); 2014 Jul; 92(7):779-92. PubMed ID: 24722948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
    Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
    Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
    Barutta F; Bellini S; Mastrocola R; Gambino R; Piscitelli F; di Marzo V; Corbetta B; Vemuri VK; Makriyannis A; Annaratone L; Bruno G; Gruden G
    Br J Pharmacol; 2018 Dec; 175(23):4371-4385. PubMed ID: 30184259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage.
    Kim J; Sohn E; Kim CS; Kim JS
    J Comp Pathol; 2011 Jan; 144(1):41-7. PubMed ID: 20541219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
    Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway.
    Gagliardini E; Perico N; Rizzo P; Buelli S; Longaretti L; Perico L; Tomasoni S; Zoja C; Macconi D; Morigi M; Remuzzi G; Benigni A
    Am J Pathol; 2013 Jul; 183(1):119-30. PubMed ID: 23707238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.